bond3study.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow:

Meta Tags

Title	Home - BOND-003
Description	BOND-003 Study is a Study of Intravesical CG0070 for the Treatment of Patients with Non-Muscle Invasive Bladder Cancer
Keywords	N/A

Server Information

WebSite	bond3study.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

bond3study.com Valuation

US$1,365

Last updated: 2023-05-20 07:23:58

bond3study.com has Semrush global rank of 0. bond3study.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. bond3study.com receives approximately 157 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, bond3study.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,365
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$37
Yearly Ads Revenue	US$453
Daily Unique Visitors	10
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
bond3study.com.	A	3600	IP: 23.236.62.147
bond3study.com.	NS	86400	NS Record: ns15.wixdns.net.
bond3study.com.	NS	86400	NS Record: ns14.wixdns.net.
bond3study.com.	TXT	3600	TXT Record: facebook-domain-verification=z22k52b2qe29fsigw4xrypcok1xc43

HtmlToTextCheckTime:2023-05-20 07:23:58

Home Patient Eligibility Site Locator FAQs Contact LOGIN Select Page BOND-003 Study Check your trial eligibility Clinicaltrials.gov ID: NCT04452591 CG Oncology Study ID: Cretostimogene grenadenorepvec (CG0070) Condition: Non-Muscle Invasive Bladder Cancer Contact: Recruitment@cgoncology.com A Study of Intravesical CG0070 for Treatment of Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) The BOND-003 study is testing an investigational drug called cretostimogene grenadenorepvec (CG0070) for adults with non-muscle invasive bladder cancer (NMIBC) who have already tried BCG treatment. Cretostimogene grenadenorepvec (CG0070) is a type of immunotherapy, which is different from chemotherapy. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. In this study, Cretostimogene grenadenorepvec (CG0070) will be given intravesically, meaning it is put directly into the bladder using a catheter (a thin tube put into your bladder). Throughout the study

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sun, 22 Jan 2023 08:50:29 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.bond3study.com/
strict-transport-security: max-age=3600
Age: 64423
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=uw2-pub-1
X-Seen-By: tHzHG6QeSsyukPkElY9D5KnPWIDxfKj16yM6xXYJ3IE=,GXNXSWFXisshliUcwO20Naon851uhK6HRsxREnrEO9YKGynm8Djty9JDEh6daXW1muOkfcTSJaUOHlD2KQbqrA==,m0j2EEknGIVUW/liY8BLLpLkXwApeozbAp9OYhJGBzcG/hKs8AeY1T4OIbgnD+yx,2d58ifebGbosy5xc+FRalt8ScUzxcjbknRZexJW15661/SPebQieS1xO77DAY4hwdNcUqQyZ/GQXrjBTmT42ng==,2UNV7KOq4oGjA5+PKsX47JjLZuMrpDbLfn1t/wd3T8wR2rxCTgaJ7/K2Kx9jhAfC
Cache-Control: no-cache
X-Wix-Request-Id: 1674377429.503160849451122095
X-Content-Type-Options: nosniff

HTTP/2 200 
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"1fec4185600b258c4ad2231c8f3265d6"
content-language: en-US
strict-transport-security: max-age=3600
x-wix-request-id: 1674377429.7404949968402629545
cache-control: public,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
accept-ranges: bytes
date: Sun, 22 Jan 2023 08:50:29 GMT
age: 101896
x-served-by: cache-hhn-etou8220063-HHN
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=hit, varnish;desc=hit_miss, dc;desc=fastly_g
set-cookie: ssr-caching=cache#desc=hit#varnish=hit_miss#dc#desc=fastly_g; max-age=20
x-seen-by: yvSunuo/8ld62ehjr5B7kA==,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,GXNXSWFXisshliUcwO20NU53gQymTA7BCiXxfWA0+JdVFUpF0ES3KLXUTKpcHMA3,m0j2EEknGIVUW/liY8BLLqe0L1PnLg6FLWqrGNmqNwAa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalsvCaFtVDTO47elf0aE/pIBmlC+yl8POBIOZu4IbedkUcWNk5DkWxetrGXmCrw+dkw==,2UNV7KOq4oGjA5+PKsX47Mf8s35TOGDl04KsxB8N+c0fbJaKSXYQ/lskq2jK6SGP
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

bond3study.com valuation and analysis